Comparison of Postoperative Effects of PRF and Corticosteroid Treatments in Impacted Third Molar Surgery
| Registry | NCT07742826 |
|---|---|
| Status | Recruiting |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: single, treatment |
| Enrollment | 60 (Estimated) |
| Sponsor | Final International University (Other) |
| Conditions | Impacted Mandibular Third Molar Extraction, Impacted Lower Third Molar, Impacted Wisdom Tooth |
| Interventions | Platelet-rich fibrin (PRF), Dexamethasone, Amoxicillin/Clavulanic Acid, Paracetamol, Chlorhexidine (Biological, drug) |
| Dates | start 2024-09-03, primary completion 2026-08-01 (estimated), completion 2026-08-01 (estimated), first posted 2026-08-03, last updated 2026-08-03 |
| Locations | 1 site in Cyprus |
Related Papers Related Patents Related Grants Related Experts
All trials for Impacted Mandibular Third Molar Extraction All trials for Impacted Lower Third Molar All trials of Platelet-rich fibrin (PRF) All trials of Dexamethasone
This prospective, randomized interventional study aims to compare the postoperative effects of standard treatment (control), platelet-rich fibrin (PRF), and PRF combined with corticosteroid treatment in patients undergoing impacted mandibular third molar surgery. A total of 60 participants will be randomly assigned to one of three treatment groups according to the study protocol. Postoperative pain, facial swelling, and trismus will be evaluated on postoperative days 1, 2, 3, and 7. The findings of this study are expected to provide evidence regarding the effectiveness of PRF alone and PRF combined with corticosteroid treatment in reducing postoperative complications following impacted mandibular third molar surgery.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Standard Postoperative Treatment (Control) | Active comparator | Drug: Amoxicillin/Clavulanic Acid; Drug: Paracetamol; Drug: Chlorhexidine | Participants receive standard postoperative treatment following impacted mandibular third molar surgery, including amoxicillin/clavulanic acid (Augmentin), paracetamol, and chlorhexidine mouthwash. No platelet-rich fibrin (PRF) or corticosteroid is administered. |
| Platelet-Rich Fibrin (PRF) | Experimental | Biological: Platelet-rich fibrin (PRF); Drug: Amoxicillin/Clavulanic Acid; Drug: Paracetamol; Drug: Chlorhexidine | Participants receive platelet-rich fibrin (PRF) placed into the extraction socket in addition to standard postoperative treatment consisting of amoxicillin/clavulanic acid (Augmentin), paracetamol, and chlorhexidine mouthwash following impacted mandibular third molar surgery. |
| Platelet-Rich Fibrin Plus Corticosteroid | Experimental | Biological: Platelet-rich fibrin (PRF); Drug: Dexamethasone; Drug: Amoxicillin/Clavulanic Acid; Drug: Paracetamol; Drug: Chlorhexidine | Participants receive platelet-rich fibrin (PRF) placement into the extraction socket followed by intramuscular corticosteroid administration, in addition to standard postoperative treatment consisting of amoxicillin/clavulanic acid (Augmentin), paracetamol, and chlorhexidine mouthwash following impacted mandibular third molar surgery. |
Sex: All, ages: 18 Years to any, accepts healthy volunteers
Inclusion Criteria: * Patients aged 18 years and older. * Patients with good general health * Patients with complete clinical and radiographic examination (panoramic radiograph/CBCT if applicable) * Patients willing and able to attend all postoperative follow-up visits Exclusion Criteria: * Patients with systemic diseases that may impair wound healing (e.g., uncontrolled diabetes, immunodeficiency). * Pregnant or breastfeeding women. * Patients with acute infection, abscess, or pericoronitis at the surgical site. * Patients with a history of allergy or contraindication to corticosteroids, local anesthetics, or prescribed medications. * Patients using corticosteroids, anticoagulants, immunosuppressive drugs, or bisphosphonates. * Patients with bleeding disorders. * Patients with previous radiotherapy to the head and neck region. * Patients unable or unwilling to comply with the study protocol or attend follow-up visits.
| Facility | City | Country | Status |
|---|---|---|---|
| Final International University Faculty of Dentistry | Nicosia | Cyprus | Recruiting |